MedTrace Logo

The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation

NCT04626427 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2025-01-16

Study results available
· View outcomes & findings →

Summary

This is a global, multi-center, prospective, post-market, confirmatory, interventional, non-randomized, single-arm clinical investigation evaluating arteriovenous fistula (AVF) creation by means of the WavelinQ™ EndoAVF System in patients who require a vascular access for hemodialysis (HD).

Conditions

Interventions

DEVICE

WavelinQ™ EndoAVF System

AVF endovascular creations using the WavelinQ™ EndoAVF System

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Principal Investigators

  • Charmaine Lok, MD, MSc · University Health Network, Toronto

  • Nicholas Inston, PhD · The Queen Elizabeth Hospital

  • Panagiotis Kitrou, MD, MSc, PhD · University Hospital of Patras

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-23
Primary Completion
2022-06-15
Completion
2022-06-15

Countries

  • Belgium
  • Greece
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04626427 on ClinicalTrials.gov